What is the recommended management for a chalazion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Chalazion Management

First-Line Treatment: Conservative Management

Start all chalazia with warm compresses applied for 5-10 minutes, 3-4 times daily, combined with eyelid hygiene and gentle massage—this approach resolves approximately 80% of cases within 4-6 weeks. 1, 2

Conservative Treatment Protocol

  • Apply warm compresses to the affected eyelid for 5-10 minutes, 3-4 times daily, to promote drainage of the obstructed meibomian gland 1, 2
  • Perform gentle massage of the affected area immediately after warm compresses to help express the obstructed gland 1, 2
  • Institute eyelid hygiene by cleaning the eyelid margins with mild soap or commercial eyelid cleansers 1, 2
  • Conservative therapy alone achieves approximately 80% resolution rates 3

Critical Timing Consideration

  • Do not continue conservative management beyond 4-6 weeks without reassessment, as prolonged conservative treatment delays diagnosis of potential sebaceous carcinoma, particularly in elderly patients 1, 2

Second-Line Treatment: Intralesional Steroid Injection

For chalazia persisting after 4-6 weeks of conservative therapy, inject triamcinolone acetonide directly into the lesion before considering surgery. 1, 2

Steroid Injection Details

  • Intralesional triamcinolone acetonide achieves a 93.8% success rate compared to 58.3% with conservative management alone 1
  • In pediatric patients, 75% of chalazia resolve after a single injection, with most remaining cases responding to a second or third injection 4
  • Re-evaluate within a few weeks after injection to assess response and check intraocular pressure 1

Common Pitfall

  • Hypopigmentary skin changes can occur at the injection site, particularly with transcutaneous injections 1, 4

Surgical Management

Reserve incision and curettage for chalazia that fail steroid injection or have features suggesting infection. 4

Surgical Indications

  • Failure of conservative management and steroid injection 1, 2
  • Infected chalazia requiring drainage 4
  • Large, recurrent, or multiple chalazia may benefit from combined incision, curettage, and intralesional steroid injection (100% resolution rate in pediatric studies) 4

CRITICAL RED FLAGS: When to Biopsy

Always biopsy recurrent chalazia in the same location, especially in elderly patients, as sebaceous carcinoma commonly masquerades as chalazion. 1, 2, 5

Mandatory Biopsy Indications

  • Recurrence in the same location, particularly in elderly patients 1, 2, 5
  • Marked asymmetry or resistance to standard therapy 1, 2
  • Unifocal recurrent chalazia unresponsive to therapy 1
  • Atypical features including eyelid margin distortion, focal lash loss (madarosis), or ulceration 1, 5
  • Unilateral chronic blepharitis unresponsive to therapy 1, 5
  • History of multiple excisions at the same site 5
  • Cutaneous squamous cell carcinoma can also masquerade as chalazion, though this is exceedingly rare 6

Addressing Underlying Conditions

Treat any associated bacterial blepharitis or meibomian gland dysfunction before addressing the chalazion, as these are common predisposing factors. 1, 2

Evaluation and Treatment

  • Evaluate for meibomian gland dysfunction, rosacea, or seborrheic dermatitis in patients with recurrent chalazia 1, 2, 5
  • Institute regular eyelid hygiene for patients with blepharitis 1, 2, 5
  • Consider systemic antibiotics for severe underlying blepharitis 1
  • Treat underlying skin conditions (rosacea, seborrheic dermatitis) to prevent recurrence 1, 2, 5

Emerging Treatment Options

Intense pulsed light (IPL) with meibomian gland expression shows promise for recurrent multiple chalazia resistant to conventional therapy. 1, 2

IPL Considerations

  • IPL demonstrates high Demodex eradication rates and improved meibum quality compared to topical treatments 1
  • Use IPL with caution in darkly pigmented individuals (above Fitzpatrick skin type IV) due to risk of burns and pigmentation changes 1, 2
  • Vectored thermal pulsation therapy may improve meibomian gland function 1

Pediatric Considerations

Children with chalazia should be evaluated for chronic blepharokeratoconjunctivitis, which often presents with recurrent conjunctivitis, keratitis, neovascularization, and eyelid inflammation. 1, 2, 5

Pediatric Red Flags Requiring Ophthalmology Referral

  • Visual loss 1, 5
  • Moderate to severe pain (may indicate acute hordeolum, secondary infection, or atypical presentation) 1, 5
  • Severe or chronic redness 1, 5

Prevention Strategies

  • Maintain regular eyelid hygiene for patients prone to recurrent chalazia, especially those with blepharitis or meibomian gland dysfunction 1, 2, 5
  • Avoid eye makeup during active inflammation 1, 5
  • Treat underlying conditions proactively 1, 2, 5

References

Guideline

Chalazion Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Chalazion Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Conservative treatment of chalazia.

Ophthalmology, 1980

Research

Three methods of treatment of chalazia in children.

Saudi medical journal, 2001

Guideline

Chalazion and Hordeolum Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.